Category: Immunosuppressive

Ustekinumab Overview

Ustekinumab,[5] sold under the brand name Stelara®, is a monoclonal antibody medication developed by Janssen Pharmaceuticals, for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis,[6] targeting both IL-12 and IL-23. Stelara® is approved to treat Crohn's disease in the United States, Israel, Australia, and the European Union (EU), and ulcerative colitis in the US, and in the EU to patients who have not respo...

Read more Ustekinumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Ustekinumab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 130mg/26ml, 45mg/0.5ml, 90mg/1ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Ustekinumab or a similar ingredient: (1 result)